These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33564428)

  • 1. Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes.
    Magalhães P; Zürbig P; Mischak H; Schleicher E
    Clin Kidney J; 2021 Jan; 14(1):269-276. PubMed ID: 33564428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of urinary fetuin-A with histopathology and kidney events in biopsy-proven kidney disease.
    Tsai MT; Tseng WC; Lee KH; Lin CC; Ou SM; Li SY
    Clin Kidney J; 2024 Apr; 17(4):sfae065. PubMed ID: 38577269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A.
    Wagner R; Machann J; Guthoff M; Nawroth PP; Nadalin S; Saleem MA; Heyne N; Königsrainer A; Fend F; Schick F; Fritsche A; Stefan N; Häring HU; Schleicher E; Siegel-Axel DI
    Sci Rep; 2017 May; 7(1):2261. PubMed ID: 28536464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary peptidomics and bioinformatics for the detection of diabetic kidney disease.
    Brondani LA; Soares AA; Recamonde-Mendoza M; Dall'Agnol A; Camargo JL; Monteiro KM; Silveiro SP
    Sci Rep; 2020 Jan; 10(1):1242. PubMed ID: 31988353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients.
    Jiang X; Zhang Q; Wang HB; Cui XF; Liu R
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28236320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.
    Roos M; Oikonomou D; von Eynatten M; Luppa PB; Heemann U; Lutz J; Baumann M; Nawroth PP; Bierhaus A; Humpert PM
    Cardiovasc Diabetol; 2010 Sep; 9():48. PubMed ID: 20822519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study.
    Ix JH; Chertow GM; Shlipak MG; Brandenburg VM; Ketteler M; Whooley MA
    Nephrol Dial Transplant; 2006 Aug; 21(8):2144-51. PubMed ID: 16644775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?
    Carpes LS; Nicoletto BB; Canani LH; Rheinhemer J; Crispim D; Souza GC
    PLoS One; 2021; 16(6):e0253501. PubMed ID: 34170951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular and tubular damage markers are elevated in patients with diabetes.
    Nauta FL; Boertien WE; Bakker SJ; van Goor H; van Oeveren W; de Jong PE; Bilo H; Gansevoort RT
    Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
    Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
    Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
    Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
    Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Estimated Glomerular Filtration Rate and Albuminuria in Predicting Cardiovascular Risk in Patients with Type 2 Diabetes without Cardiovascular Disease.
    Weerarathna T; Liyanage G; Herath M; Weerarathna M; Amarasinghe I
    Biomed Res Int; 2018; 2018():8178043. PubMed ID: 30729117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes.
    Rasul S; Ilhan A; Reiter MH; Todoric J; Farhan S; Esterbauer H; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):499-505. PubMed ID: 21958193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury.
    Zhou H; Pisitkun T; Aponte A; Yuen PS; Hoffert JD; Yasuda H; Hu X; Chawla L; Shen RF; Knepper MA; Star RA
    Kidney Int; 2006 Nov; 70(10):1847-57. PubMed ID: 17021608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center.
    Sugiyama S; Jinnouchi H; Yoshida A; Hieshima K; Kurinami N; Jinnouchi K; Tanaka M; Suzuki T; Miyamoto F; Kajiwara K; Jinnouchi T
    J Clin Med Res; 2019 Apr; 11(4):267-274. PubMed ID: 30937117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients.
    Markoska K; Pejchinovski M; Pontillo C; Zürbig P; Jacobs L; Smith A; Masin-Spasovska J; Stojceva-Taneva O; Polenakovic M; Magni F; Mischak H; Spasovski G
    Nephrol Dial Transplant; 2018 May; 33(5):751-759. PubMed ID: 28992073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.